News Chart Celon Pharma S.A.

Equities

CLN

PLCLNPH00015

Delayed Warsaw S.E. Other stock markets 12:59:01 06/06/2024 BST			5-day change	1st Jan Change
15.56 ^PLN	-0.38%		-0.13%	+0.65%

05-22	Celon Pharma S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-22	Novohale Therapeutics, LLC announced that it expects to receive $30 million in funding from Tang Capital Management, LLC, Celon Pharma S.A.	CI

29079263b2fe430c4e89963c7b8e474._kLwznc81n8eylSomnPYC9MnDb7f9FuGhAotAXydYd4.kiqxrw1SlBp1-wPj9hDqaJISZvatkj3v_lxGNhOkL464Lbz9Jgy1K0GlEQ~e4e187fa76f2769aa6c0c05b7ebe7626